DVADAVITA INC.

NYSE davita.com


$ 148.40 $ -3.19 (-2.1 %)    

Tuesday, 20-Aug-2024 12:12:44 EDT
QQQ $ 480.86 $ -0.44 (-0.09 %)
DIA $ 408.74 $ -0.15 (-0.04 %)
SPY $ 559.07 $ -0.09 (-0.02 %)
TLT $ 98.57 $ 0.27 (0.27 %)
GLD $ 231.78 $ -1.94 (-0.83 %)
$ 152.17
$ 151.59
$ 148.42 x 100
-- x --
$ 148.38 - $ 152.19
$ 71.51 - $ 152.22
643,098
na
13.54B
$ 0.80
$ 15.75
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-14-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 10-31-2022 09-30-2022 10-Q
9 08-01-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-11-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-21-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 02-22-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-01-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-24-2017 12-31-2016 10-K
32 11-02-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-05-2015 03-31-2015 10-Q
39 02-26-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-davita-raises-price-target-to-165

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $150 to $...

 ubs-maintains-buy-on-davita-raises-price-target-to-175

UBS analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Buy and raises the price target from $169 to $175.

 davita-announces-offering-of-1b-senior-notes-due-2032

DaVita Inc. (NYSE:DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of ...

 b-of-a-securities-maintains-underperform-on-davita-raises-price-target-to-145

B of A Securities analyst Kevin Fischbeck maintains DaVita (NYSE:DVA) with a Underperform and raises the price target from $...

 davita-raises-fy24-eps-guidance-from-900-980-to-925-1005-vs-932-est

Outlook:The following forward-looking measures and the underlying assumptions involve significant known and unknown risks and u...

 davita-q2-adj-259-beats-254-estimate-sales-319b-beat-315b-estimate

DaVita (NYSE:DVA) reported quarterly earnings of $2.59 per share which beat the analyst consensus estimate of $2.54 by 1.97 per...

 td-cowen-maintains-hold-on-davita-raises-price-target-to-150

TD Cowen analyst Gary Taylor maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $139 to $150.

 financial-crime-weekly-davita-agrees-to-pay-345m-for-kickbacks-hospice-provider-doles-out-194m-for-false-claims

DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for p...

 davita-to-pay-over-34m-to-settle-illegal-kickback-allegations

- Bloomberg Citing DOJ

 fresenius-ses-future-with-dialysis-company-unclear-investors-seek-answers

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite hol...

 truist-securities-maintains-hold-on-davita-raises-price-target-to-150

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $135 to $...

 barclays-maintains-equal-weight-on-davita-raises-price-target-to-150

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $133 to $150.

 davita-q1-2024-adj-eps-238-beats-195-estimate-sales-3071b-beat-3028b-estimate

DaVita (NYSE:DVA) reported quarterly Adj earnings of $2.38 per share which beat the analyst consensus estimate of $1.95 by 22.0...

 the-american-diabetes-association-and-davita--announce-expansion-of-a-multi-year-collaboration-focused-on-advancing-chronic-disease-prevention-specifically-addressing-diabetes-and-chronic-kidney-disease

Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National K...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION